Trials / Completed
CompletedNCT03603444
Reliability of Serum Calcium to Phosphorus (Ca/P) Ratio as an Accurate and Inexpensive Tool to Define Disorders of Ca-P Metabolism
Serum Calcium to Phosphorus (Ca/P) Ratio to Define Disorders of Ca-P Metabolism
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 606 (actual)
- Sponsor
- Azienda Ospedaliero-Universitaria di Modena · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- —
Summary
BACKGROUND: Primary hyperparathyroidism (PHPT) is the third most common endocrine disorder. The Ca/P ratio is an accurate tool to differentiate patients with PHPT (\>3.5 if Ca and P are expressed in mg/dl) from healthy subjects. The reliability of this index is based on the fact that serum Ca and P are inversely related together. However, other disorders of the Ca-P metabolism, such as hypophosphoremia (HypoP) not related to PHPT, might also impair the Ca/P ratio. OBJECTIVE: To validate the accuracy of Ca/P ratio in the diagnosis of Ca-P metabolism disorders, including also patients with documented HypoP not related to PHPT. METHODS: A single-center, retrospective, case-control study will be carried out. Biochemical measurements will include parathormone (PTH), vitamin D, serum Ca and P, serum albumin and creatinine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention are provided |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2018-07-27
- Last updated
- 2018-07-27
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03603444. Inclusion in this directory is not an endorsement.